Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Timothy E. O’Sullivan is active.

Publication


Featured researches published by Timothy E. O’Sullivan.


Journal of Experimental Medicine | 2012

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

Timothy E. O’Sullivan; Robert Saddawi-Konefka; William Vermi; Catherine M. Koebel; Cora D. Arthur; J. Michael White; Ravi Uppaluri; Daniel M. Andrews; Shin Foong Ngiow; Michele W. L. Teng; Mark J. Smyth; Robert D. Schreiber; Jack D. Bui

In the absence of adaptive immunity, NK cells polarize M1 macrophages to facilitate cancer immunoediting.


Journal of Experimental Medicine | 2014

Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens

Theresa L. Geiger; Michael C. Abt; Georg Gasteiger; Matthew A. Firth; Margaret H. O’Connor; Clair D. Geary; Timothy E. O’Sullivan; Marcel R.M. van den Brink; Eric G. Pamer; Alan M. Hanash; Joseph C. Sun

Nfil3 is critical for normal development of innate lymphoid cell (ILC) progenitors. Nfil3-deficient mice have severely reduced lung and visceral adipose tissue ILC2s and gut-associated ILC3s, and compromised innate immunity to acute bacterial infection.


Immunity | 2015

Natural Killer Cell Memory

Timothy E. O’Sullivan; Joseph C. Sun; Lewis L. Lanier

Natural killer (NK) cells have historically been considered short-lived cytolytic cells that can rapidly respond against pathogens and tumors in an antigen-independent manner and then undergo cell death. Recently, however, NK cells have been shown to possess traits of adaptive immunity and can acquire immunological memory in a manner similar to that of T and B cells. In this review, we discuss evidence of NK cell memory and the mechanisms involved in the generation and survival of these innate lymphocytes.


Cell Reports | 2014

Interleukin-17D Mediates Tumor Rejection through Recruitment of Natural Killer Cells

Timothy E. O’Sullivan; Robert Saddawi-Konefka; Emilie Gross; Miller Tran; Stephen P. Mayfield; Hiroaki Ikeda; Jack D. Bui

The process of cancer immunoediting generates a repertoire of cancer cells that can persist in immune-competent hosts. In its most complex form, this process begins with the elimination of highly immunogenic unedited tumor cells followed by the escape of less immunogenic edited cells. Although edited tumors can release immunosuppressive factors, it is unknown whether unedited tumors produce cytokines that enhance antitumor function. Utilizing gene microarray analysis, we found the cytokine interleukin 17D (IL-17D) was highly expressed in certain unedited tumors but not in edited mouse tumor cell lines. Moreover, forced expression of IL-17D in edited tumor cells induced rejection by stimulating MCP-1 production from tumor endothelial cells, leading to the recruitment of natural killer (NK) cells. NK cells promoted M1 macrophage development and adaptive immune responses. IL-17D expression was also decreased in certain high-grade and metastatic human tumors, suggesting that it can be targeted for tumor immune therapy.


Journal of Immunology | 2011

Cancer Immunoediting of the NK Group 2D Ligand H60a

Timothy E. O’Sullivan; Gavin P. Dunn; Daphne Lacoursiere; Robert D. Schreiber; Jack D. Bui

Cancer immunoediting describes the process whereby highly immunogenic tumor cells are removed, or edited, from the primary tumor repertoire by the immune system. In immunodeficient mice, the editing process is hampered, and “unedited” tumor cells can be recovered and studied. In this study, we compared unedited and edited tumors for their expression of NK group 2D (NKG2D) ligands, a family of surface proteins expressed on tumor cells that can activate NK cell cytotoxic activity. We found that the expression of the NKG2D ligand H60a was more heterogeneous in groups of unedited 3′-methylcholanthrene sarcoma cell lines compared with that in edited 3′-methylcholanthrene sarcoma cell lines (i.e., some unedited cell lines expressed very high levels of H60a, whereas other unedited and edited cell lines expressed very low levels). We also found that some highly immunogenic cell lines displayed a bimodal distribution consisting of H60a-hi and H60a-lo cells. In one of these cell lines, the H60a-hi cells could be removed by passaging the cells through RAG2−/− mice, resulting in edited cell lines that were poor targets for NK cells and that displayed progressive tumor growth. This editing of H60a-hi cells required NK cells and NKG2D. Our studies show that the expression of H60a on tumors cells can be actively modulated by the immune system, thereby implicating this NKG2D ligand in tumor immunosurveillance.


Cell Reports | 2016

Atg5 Is Essential for the Development and Survival of Innate Lymphocytes.

Timothy E. O’Sullivan; Clair D. Geary; Orr-El Weizman; Theresa L. Geiger; Moritz Rapp; Gerald W. Dorn; Michael Overholtzer; Joseph C. Sun

Autophagy is an essential cellular survival mechanism that is required for adaptive lymphocyte development; however, its role in innate lymphoid cell (ILC) development remains unknown. Furthermore, the conditions that promote lymphocyte autophagy during homeostasis are poorly understood. Here, we demonstrate that Atg5, an essential component of the autophagy machinery, is required for the development of mature natural killer (NK) cells and group 1, 2, and 3 innate ILCs. Although inducible ablation of Atg5 was dispensable for the homeostasis of lymphocyte precursors and mature lymphocytes in lymphoreplete mice, we found that autophagy is induced in both adaptive and innate lymphocytes during homeostatic proliferation in lymphopenic hosts to promote their survival by limiting cell-intrinsic apoptosis. Induction of autophagy through metformin treatment following homeostatic proliferation increased lymphocyte numbers through an Atg5-dependent mechanism. These findings highlight the essential role for autophagy in ILC development and lymphocyte survival during lymphopenia.


Science immunology | 2017

Core-binding factor β and Runx transcription factors promote adaptive natural killer cell responses

Moritz Rapp; Colleen M. Lau; Nicholas M. Adams; Orr-El Weizman; Timothy E. O’Sullivan; Clair D. Geary; Joseph C. Sun

Runx1 and Runx3 play nonredundant roles in promoting the clonal expansion of NK cells during viral infection. Memory wiring in natural killer cells Although clonal expansion and immune memory are associated with adaptive immunity, Ly49H-expressing natural killer (NK) cells undergo clonal proliferation in response to mouse cytomegalovirus (MCMV) infection and form long-lived memory cells. Previous studies have shown that interleukin-12, via activation of signal transducer and activator of transcription 4 (STAT4), drives expansion of MCMV-responsive NK cells. Here, by carrying out ChIP-seq to identify downstream targets of STAT4, Rapp et al. demonstrate that genes encoding transcription factors Runx1 and Runx3 are direct targets of STAT4. By further evaluating the ability of Runx1- and Runx3-deficient NK cells to respond to MCMV infection, they show that Runx1 and Runx3 play nonredundant roles in promoting clonal expansion of NK cells. Natural killer (NK) cells are innate lymphocytes that have features of adaptive immunity such as clonal expansion and generation of long-lived memory. Interleukin-12 (IL-12) signaling through its downstream transcription factor signal transducer and activator of transcription 4 (STAT4) is required for the generation of memory NK cells after expansion. We identify gene loci that are highly enriched for STAT4 binding using chromatin immunoprecipitation sequencing for STAT4 and the permissive histone mark H3K4me3 in activated NK cells. We found that promoter regions of Runx1 and Runx3 are targets of STAT4 and that STAT4 binding during NK cell activation induces epigenetic modifications of Runx gene loci resulting in increased expression. Furthermore, specific ablation of Runx1, Runx3, or their binding partner Cbfb in NK cells resulted in defective clonal expansion and memory formation during viral infection, with evidence for Runx1-mediated control of a cell cycle program. Thus, our study reveals a mechanism whereby STAT4-mediated epigenetic control of individual Runx transcription factors promotes the adaptive behavior of antiviral NK cells.


Journal of Immunology | 2016

NK Cell Responses Redefine Immunological Memory

Nicholas M. Adams; Timothy E. O’Sullivan; Clair D. Geary; Jenny M. Karo; Robert A. Amezquita; Nikhil S. Joshi; Susan M. Kaech; Joseph C. Sun

Immunological memory has traditionally been regarded as a unique trait of the adaptive immune system. Nevertheless, there is evidence of immunological memory in lower organisms and invertebrates, which lack an adaptive immune system. Despite their innate ability to rapidly produce effector cytokines and kill virally infected or transformed cells, NK cells also exhibit adaptive characteristics such as clonal expansion, longevity, self-renewal, and robust recall responses to antigenic or nonantigenic stimuli. In this review, we highlight the intracellular and extracellular requirements for memory NK cell generation and describe the emerging evidence for memory precursor NK cells and their derivation.


OncoImmunology | 2014

Tumor-expressed IL-17D recruits NK cells to reject tumors.

Robert Saddawi-Konefka; Timothy E. O’Sullivan; Emilie Gross; Allen Washington; Jack D. Bui

Antitumor immunity suppresses tumorigenesis, but we do not understand how transformed cells initiate those immune responses that are essential for effective tumor immunosurveillance. Using the 3-MCA fibrosarcoma model, we identified IL-17D as a tumor-expressed cytokine that recruits natural killer cells, leading to the polarization of M1 macrophages and tumor rejection.


Immunity | 2015

BNIP3- and BNIP3L-Mediated Mitophagy Promotes the Generation of Natural Killer Cell Memory.

Timothy E. O’Sullivan; Lexus R. Johnson; Helen H. Kang; Joseph C. Sun

Collaboration


Dive into the Timothy E. O’Sullivan's collaboration.

Top Co-Authors

Avatar

Joseph C. Sun

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Jack D. Bui

University of California

View shared research outputs
Top Co-Authors

Avatar

Clair D. Geary

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Moritz Rapp

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Nicholas M. Adams

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Orr-El Weizman

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Emilie Gross

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge